Opendata, web and dolomites


Lifecare’s Sencell sensor is an implantable micro-sensor for subcutaneous location, long time, continuous, wireless, real time monitoring of interstitial glucose for diabetes management.

Total Cost €


EC-Contrib. €






 Sencell16 project word cloud

Explore the words cloud of the Sencell16 project. It provides you a very rough idea of what is the project "Sencell16" about.

dextran    insertion    fluid    substances    unlike    physical    signals    warning    protruding    enclosed    mobile    designed    user    proprietary    interstitial    cavity    cona    skin    device    doses    pressure    signal    covered    independently    enzymatic    places    final    autonomously    subcutaneous    glucose    insulin    inside    inner    transmitter    core    translates    blood    wrist    contains    membrane    hyperglycemia    arm    sensitivity    prompting    intended    implanted    permeable    alternatives    suitable    sugar    noninvasively    encased    utilizes    biocompatible    material    concanavalin    monitoring    automatically    generate    osmotic    improves    reading    longer    induce    semi    sensor    accurate    body    sensors    reducing    located    influence    miniaturized    time    subcutaneously    sencell    patented    operation    medical    relayed    communication    space    wires    cell    sites    transducer    hypoglycemia    entire    significantly    battery    function   

Project "Sencell16" data sheet

The following table provides information about the project.


Organization address
address: OVRE KRAKENES 17
city: BERGEN
postcode: 5152

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-08-01   to  2016-12-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIFECARE AS NO (BERGEN) coordinator 50˙000.00


 Project objective

The SENCELL Glucose Monitoring System includes an osmotic pressure sensor, transmitter and mobile medical application. The miniaturized sensor is designed to be implanted into the subcutaneous space of arm wrist or other suitable body sites and requires no battery or wires for the sensor operation and for communication with the transmitter. After insertion, the sensor is designed to function noninvasively, automatically, and continuously for a long term duration that is comparable or longer than existing product alternatives.

The miniaturized SENCELL is designed to continuously measure glucose in the interstitial fluid for a long term duration that is comparable or longer than existing product alternatives. Unlike currently used glucose sensors, the Sencell is intended to be implanted subcutaneously on the arm wrist or other subcutaneous places in the body with no sensor part protruding from the skin.

Encased in a biocompatible material, the device utilizes a unique osmotic pressure assessment technology, which translates the signal of a physical miniaturized osmotic pressure cell into an accurate glucose reading that can be used for determination of insulin doses and to generate warning signals in case of hypoglycemia or hyperglycemia development.

The inner core of the device is the unique and proprietary osmotic patented pressure cell, which is covered on one side by a semi-permeable membrane. The membrane is enclosed inside the top of a cavity where the pressure transducer is also located. The cavity contains Concanavalin A and Dextran.

The use of ConA/Dextran as enzymatic component significantly improves the sensitivity to changes in the blood sugar level while reducing the influence from other substances in the blood. In the final product, the measurement is then relayed to the transmitter. The entire measurement is designed to be done autonomously and independently without any prompting by the user. However, the user can induce a measurement at any time

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SENCELL16" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SENCELL16" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

AutoCRAT (2020)

Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis

Read More